If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.


Biological Chemistry

Ubiquitin Variants Reveal New Inhibitors

Combinatorial screening library identifies inhibitors of deubiquitinating enzymes that could serve as probes of cell-signaling processes

by Stu Borman
January 7, 2013 | A version of this story appeared in Volume 91, Issue 1

Scientists have developed and exploited a set of ubiquitin variants that could lead to a better understanding of the way the peptides help manage cellular functions. Ubiquitins regulate cells by a signaling process that is activated via their attachment to key cellular proteins. Deubiquitinating enzymes later remove these ubiquitin tags from the proteins. The enzymes also play a role in some cancers and neurodegenerative, hematologic, and infectious diseases. Inhibitors can be used to study the enzymes’ roles, but only a few weak inhibitors have been identified. In Science, Sachdev S. Sidhu of the University of Toronto and coworkers report that they have identified potent deubiquitinating enzyme inhibitors by screening a combinatorial library of ubiquitin-like compounds (DOI: 10.1126/science.1230161). They also screened the library to find agents that inhibit enzymes that conjugate ubiquitins to proteins or recognize ubiquitin tags. The ubiquitin variants “will serve as useful genetic probes to assess and modulate ubiquitin system function in vivo,” they write.


This article has been sent to the following recipient:

Chemistry matters. Join us to get the news you need.